what is in the compound semaglutide | C187H291N45O59 | CID 56843331 Compounded Semaglutide ODT (oral dissolving
Description
Reddy's Laboratories and Apotex were approved earlier this year

Real-World Comparison of Oral Versus Injectable Semaglutide

Thus, blockade of hepatic portal GLP-1R signaling causes glucose intolerance in rats, suggesting that GLP-1Rs located on nerve terminals in the hepatic portal vein contribute to the incretin action of GLP-1 (Vahl et al., Rodent studies involving pharmacological manipulation of GLP-1R in the brain by intracerebroventricular (ICV) administration of agonists and antagonists demonstrate a role for brain GLP-1R signaling in the control of glucose metabolism

Blood work is supposed to bring clarity, but for people taking semaglutide, it can do the opposite

The advantage here is obvious

Previously approved only as an intravenous starting dosage, with the option for transitioning to intravenous or subcutaneous maintenance dosage after 18 months of treatment, this approval marks the first time patients can begin treatment with home administration by themselves or their caregiver
